Sign in

CIK 0001516551

  • Non-accelerated filer
  • Smaller reporting company

Skye Bioscience, Inc.

Sign in to watch
Ticker
SKYE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
450692882
Phone
+1 858-410-0266
Business address
11250 EL CAMINO REAL, SUITE 100, SAN DIEGO, CA, 92130
Former names
Emerald Bioscience, Inc., Nemus Bioscience, Inc., LOAD GUARD LOGISTICS, INC., LOAD GUARD TRANSPORTATION, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$613,506
in 6 filings

Net −$613,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-02-29 Charych Deborah H. Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2024-02-29 Jenkins Annalisa Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2024-02-29 Schwab Andrew J. Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2024-02-29 DALESANDRO MARGARET Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2024-02-29 Ward Keith Wayne Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2024-02-29 TYLE PRAVEEN Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2024-02-29 Diep Tuan Tu Chief Development Officer Grant or award +25,000 101,833
2024-02-29 Diep Tuan Tu Chief Development Officer Grant or award · Stock Option (Right to Buy) +75,000 75,000
2024-02-29 ARSENAULT KAITLYN Chief Financial Officer Grant or award +25,000 209,738
2024-02-29 ARSENAULT KAITLYN Chief Financial Officer Grant or award · Stock Option (Right to Buy) +75,000 75,000
2024-02-29 DHILLON PUNIT Chief Executive Officer Grant or award +100,000 397,006
2024-02-29 DHILLON PUNIT Chief Executive Officer Grant or award · Stock Option (Right to Buy) +125,000 125,000
2024-02-29 ARSENAULT KAITLYN Chief Financial Officer Grant or award +25,000 210,738
2024-02-29 ARSENAULT KAITLYN Chief Financial Officer Grant or award · Stock Option (Right to Buy) +75,000 75,000
2024-02-29 DHILLON PUNIT Chief Executive Officer Grant or award +100,000 397,006
2024-02-29 DHILLON PUNIT Chief Executive Officer Grant or award · Stock Option (Right to Buy) +125,000 125,000
2024-01-31 Schwab Andrew J. Director Grant or award +5,206,074 $2.31 $12.0M 7,943,520
2024-01-31 5AM Partners VII, LLC 10% owner Purchase +5,206,074 $2.31 $12.0M 7,943,520
2023-11-06 Ward Keith Wayne Director Grant or award · Stock Option (Right to Buy) +14,110 20,001
2023-11-06 Charych Deborah H. Director Grant or award · Stock Option (Right to Buy) +14,110 20,001

Page 8 of 15 · 292 trades